Form 8-K - Current report:
SEC Accession No. 0001493152-25-005961
Filing Date
2025-02-11
Accepted
2025-02-11 17:27:46
Documents
17
Period of Report
2025-02-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36534
2 ex3-1.htm EX-3.1 3315
3 ex3-1_001.jpg GRAPHIC 1150028
4 ex3-1_002.jpg GRAPHIC 2484554
5 ex3-1_003.jpg GRAPHIC 1888990
  Complete submission text file 0001493152-25-005961.txt   7820997

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE exoz-20250210.xsd EX-101.SCH 3015
7 XBRL LABEL FILE exoz-20250210_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE exoz-20250210_pre.xml EX-101.PRE 22359
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3880
Mailing Address 750 ROYAL OAKS DR MONROVIA CA 91016
Business Address 750 ROYAL OAKS DR MONROVIA CA 91016 (626) - 415 - 1488
EXOZYMES INC. (Filer) CIK: 0002010788 (see all company filings)

EIN.: 834550057 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42204 | Film No.: 25610993
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)